Monocyte signature predicts dexamethasone response in severe COVID-19 patients

Post author:
Post published:July 3, 2024
Post category:uncategorized

Dexamethasone is one of the most important drugs in the treatment of severe COVID-19, but patients respond very differently to the therapy.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Eyes may be the window to your soul, but the tongue mirrors your health

Diabetes drug dulaglutide may reduce symptoms of depression

Exploring nature’s palette: The promising future of natural food colorants

Helpful Links

Subscribe To Us